On May 29, 2024, the U.S. Food and Drug Administration (“FDA”) released draft guidance titled Platform Technology Designation Program for Drug Development. The draft guidance describes the process for requesting and receiving...more
The State Department is initiating a public process to consider the implications of Access and Benefit-Sharing (ABS) regimes for global health and biomedical research. The Federal Register Notice announcing this initiative...more
6/19/2019
/ DNA ,
Genetic Materials ,
Healthcare ,
Influenza ,
Life Sciences ,
Medical Research ,
Public Health ,
Public Meetings ,
The Nagoya Protocol ,
United ,
United Nations ,
US Department of State ,
Vaccinations ,
World Health Organization